On June 23, 2020, Steve Gillis, Ph.D. tendered his resignation from the board of directors (the “Board”), and all Board committees, of Pulmatrix, Inc. (the “Company”), effective on September 1, 2020. On June 23, 2020, the Board appointed Christopher Cabell as a Class I director to serve for a term expiring at the next annual meeting of stockholders at which the term of the Class I directors expires or until his successor is duly elected and qualified, or his earlier death, resignation or removal. In addition, Dr. Cabell was appointed to the Company’s compensation committee of the Board.